IDV vehicle

36E79725D0037

NEW AWARD FOR LOSARTAN TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 9/24/2025-9/23/2026.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC PHARMACEUTICALS (36E797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$37.9M
Start dateSep 24, 2025
Current end dateNot available
Potential end dateNot available
Latest award activitySep 9, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 9, 2026P00002$0MODIFICATION TO INCORPORATE SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APR 2026), INTO THE CONTRACT.
Aug 21, 2026P00001$0EXERCISE OPTION YEAR ONE FOR 36E79725D0037 WITH NO PRICE CHANGES. THE PERIOD OF PERFORMANCE IS 9/24/2026 - 9/23/2027.
Jul 2, 20250$0NEW AWARD FOR LOSARTAN TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 9/24/2025-9/23/2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Michael J OlszewskiContract SpecialistMichael.Olszewski@va.govSourceMay 8, 2025
708-786-4966Michael Olszewskimichael.olszewski@va.gov
708-786-4966
SourceMay 1, 2025

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.